Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good afternoon, and welcome to the Ultragenyx Second Quarter 2025 ...

Prohibitionists are celebrating the inclusion of language in a major spending bill that would block a federal traffic safety ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using artificial intelligence, machine ...

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

The United States doubled its bounty on Venezuelan President, Nicolas Maduro—who faces federal drug trafficking charges—to ...

The Trump administration is doubling to $50 million a reward for the arrest of Venezuelan President Nicolás Maduro and ...

The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.

The German giant is looking to develop new drugs for undisclosed eye diseases using Re-Vana’s extended-release injectable ...

A decade ago, the National Crime Agency identified a new drug supply method. Before then, drug supply was predominantly between user-dealers – people ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events (including everything from Summerfest to the Milwaukee Film Festival), access ...

Missouri Attorney General Andrew Bailey is suing the national Planned Parenthood organization over its claims regarding the abortion drug mifepristone.